Unresectable Metastatic Colorectal Cancer Clinical Trials in Guangzhou, Guangdong

Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer